A carregar...
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges
Novel therapies are challenging the standards of drug development. Agents with specific biologic targets, unknown dose-efficacy curves, and limited toxicity mandate novel designs to identify biologically optimal doses. We review two model-based designs that utilize either a proportional odds model o...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931331/ https://ncbi.nlm.nih.gov/pubmed/20419760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.3706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|